Balance Sheet Data

Evogene Ltd. (EVGN)

$0.931

-0.06 (-5.96%)

Year
A/P
2017
Actual
2018
Actual
2019
Actual
2020
Actual
2021
Actual
2022
Projected
2023
Projected
2024
Projected
2025
Projected
2026
Projected
Total Cash 71.7554.4746.8848.2353.8732.8126.4421.3117.1713.83
Total Cash (%)
Account Receivables 0.290.460.432.032.930.900.730.590.470.38
Account Receivables (%)
Inventories ----0.090.070.060.050.040.03
Inventories (%)
Accounts Payable 1.111.0210.861.460.700.560.450.360.29
Accounts Payable (%)
Capital Expenditure -0.59-0.37-0.90-0.68-0.72-0.45-0.36-0.29-0.24-0.19
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.